Sheldon Sloan
CIK 2038798 · Chief Medical Officer · last filed 2026-07-02
Sheldon Sloan is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for SYRE, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$7.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
10
-$7.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | Chief Medical Officer | 0 | $99.96 | $0 | -$7.35M | 7 | 2026-07-02 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-02 | SYRE | Mixed | — | -$502.0K | EDGAR |
| 2026-06-03 | SYRE | Notice (144) | −16,667 | -$1.15M | EDGAR |
| 2026-06-03 | SYRE | Mixed | — | -$396.2K | EDGAR |
| 2026-05-01 | SYRE | Mixed | — | -$3.45M | EDGAR |
| 2026-05-01 | SYRE | Notice (144) | −78,333 | -$5.83M | EDGAR |
| 2026-04-03 | SYRE | Mixed | — | -$225.5K | EDGAR |
| 2026-04-01 | SYRE | Notice (144) | −7,958 | -$401.4K | EDGAR |
| 2026-01-13 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2025-01-17 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2024-10-01 | SYRE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.